TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

You Are Here: Home  »  Research Funding  »  Funding Opportunities  » 

Skip secondary menu

NINDS Neuroscience Funding Announcements

Validation of Novel Therapeutic Targets for Huntington’s Disease (R01)

Funding Contact(s): Margaret Sutherland, Ph.D.
Funding Categories: Neurodegeneration

Brief Description:

The National Institute of Neurological Disorders and Stroke (NINDS) invites research project grant (R01) applications aimed at validating novel molecular targets for disease-modifying therapeutic intervention in Huntington’s disease. This FOA is for support of new projects, and not the continuation of projects that have already been initiated with NIH funding.

Grant Mechanism: R01
NIH Guide: PAS-10-183
Release Date: 2010-04-30
Expiration Date: 2013-05-08